| pubmed-article:15147461 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15147461 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15147461 | lifeskim:mentions | umls-concept:C0072978 | lld:lifeskim |
| pubmed-article:15147461 | lifeskim:mentions | umls-concept:C0079633 | lld:lifeskim |
| pubmed-article:15147461 | lifeskim:mentions | umls-concept:C0092801 | lld:lifeskim |
| pubmed-article:15147461 | lifeskim:mentions | umls-concept:C0751967 | lld:lifeskim |
| pubmed-article:15147461 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:15147461 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:15147461 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:15147461 | pubmed:dateCreated | 2004-5-18 | lld:pubmed |
| pubmed-article:15147461 | pubmed:abstractText | Chemokines are involved in the pathogenesis of multiple sclerosis. The aim of the study was to evaluate the effects of immunosuppressive therapy on production of two proinflammatory chemokines--interleukin-8 (IL-8) and RANTES (regulated on activation, normal T cell expressed and secreted). | lld:pubmed |
| pubmed-article:15147461 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15147461 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15147461 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15147461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15147461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15147461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15147461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15147461 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15147461 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:15147461 | pubmed:issn | 0001-6314 | lld:pubmed |
| pubmed-article:15147461 | pubmed:author | pubmed-author:StelmasiakZZ | lld:pubmed |
| pubmed-article:15147461 | pubmed:author | pubmed-author:Mitosek-Szewc... | lld:pubmed |
| pubmed-article:15147461 | pubmed:author | pubmed-author:Bartosik-Psuj... | lld:pubmed |
| pubmed-article:15147461 | pubmed:author | pubmed-author:DoboszBB | lld:pubmed |
| pubmed-article:15147461 | pubmed:author | pubmed-author:BelniakEE | lld:pubmed |
| pubmed-article:15147461 | pubmed:copyrightInfo | Copyright Blackwell Munksgaard 2004 | lld:pubmed |
| pubmed-article:15147461 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15147461 | pubmed:volume | 109 | lld:pubmed |
| pubmed-article:15147461 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15147461 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15147461 | pubmed:pagination | 390-2 | lld:pubmed |
| pubmed-article:15147461 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:15147461 | pubmed:meshHeading | pubmed-meshheading:15147461... | lld:pubmed |
| pubmed-article:15147461 | pubmed:meshHeading | pubmed-meshheading:15147461... | lld:pubmed |
| pubmed-article:15147461 | pubmed:meshHeading | pubmed-meshheading:15147461... | lld:pubmed |
| pubmed-article:15147461 | pubmed:meshHeading | pubmed-meshheading:15147461... | lld:pubmed |
| pubmed-article:15147461 | pubmed:meshHeading | pubmed-meshheading:15147461... | lld:pubmed |
| pubmed-article:15147461 | pubmed:meshHeading | pubmed-meshheading:15147461... | lld:pubmed |
| pubmed-article:15147461 | pubmed:meshHeading | pubmed-meshheading:15147461... | lld:pubmed |
| pubmed-article:15147461 | pubmed:meshHeading | pubmed-meshheading:15147461... | lld:pubmed |
| pubmed-article:15147461 | pubmed:meshHeading | pubmed-meshheading:15147461... | lld:pubmed |
| pubmed-article:15147461 | pubmed:meshHeading | pubmed-meshheading:15147461... | lld:pubmed |
| pubmed-article:15147461 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15147461 | pubmed:articleTitle | Interleukin-8 and RANTES levels in patients with relapsing-remitting multiple sclerosis (RR-MS) treated with cladribine. | lld:pubmed |
| pubmed-article:15147461 | pubmed:affiliation | Department of Neurology, Medical University, Lublin, Poland. halbp@poczta.onet.pl | lld:pubmed |
| pubmed-article:15147461 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15147461 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15147461 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15147461 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15147461 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15147461 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15147461 | lld:pubmed |
